摘要
用^3H—TdR掺入法测定了62例恶性肿瘤患者血清对LAK细胞杀伤活性的影响，并与20例健康成人血清对照，结果：20例健康成人组血清作用后的LAK细胞杀伤率均值为65.85±3.55％，62例恶性肿瘤患者组血清作用后的LAK细胞杀伤率均值为49．34±6．27%，两者有非常显著差异(P<0．01)；48例有临床可见癌灶患者组血清作用后的LAK细胞杀伤率均值为49．60±6．60%，与健康成人组比较有非常显著差异(P<0.01)；14例无临床可见癌灶患者组血清作用后的LAK细胞杀伤率均值为48．47±5.11％，与健康成人组比较有非常显著差异(P<0．01)；与有临床可见癌灶患者组比较，无显著差异(P>0．05)。
~.3H-TdR insert method was used for detection the serum of 62 malignant tumour patients which exerted an in-flunce on LAK cell LETHAL activity. The results showed: the mean of lethal rate was 65. 85 ?3. 55% in the group of 20 normal adults, the mean of lethal rate in the group of 62 malignan tumour patients was 49. 34?. 27%, both difference was significant (P<0. 01). The mean of lethal rate was 49. 60?6. 60% in the group of 48 patients whose tumour focus was clinic visible, com-pared with the normal group, the difference was obvious (P<0. 01) , the mean of lethal rate was 48. 47 ?5. 11% in the group of 14 patients who had not tumour focus of clinic visible, compared with the normal group, the difference was obvious (P<0. 01), but compared with the group of clinic visible tumour focus, it had not obvious difference (P>0. 05).
出处
《临床肿瘤学杂志》
CAS
1996年第3期35-37,共3页
Chinese Clinical Oncology
关键词
恶性肿瘤
血清
LAK细胞
免疫功能
临床资料
Malignant tumour, Serum/patient, LAK cell, Lethal activity,Restrain material
